Literature DB >> 31419624

Bifunctional chemical probes inducing protein-protein interactions.

Chiara Maniaci1, Alessio Ciulli2.   

Abstract

Inducing biomolecular interactions with synthetic molecules to impact biological function is a concept of enormous appeal. Recent years have seen a resurgence of interest in designing bispecific molecules that serve as bridging agents to bring proteins together. Pioneering structural and biophysical investigation of ternary complexes formed by mono-functional and bifunctional ligands highlights that proximity-induced stabilization or de novo formation of protein-protein interactions is a common feature of their molecular recognition. In this review, we illustrate these concepts and advances with representative case studies, and highlight progress over the past three years, with particular focus on recruitment to E3 ubiquitin ligases by 'molecular glues' and chimeric dimerizers (PROTACs) for targeted protein degradation. This approach promises to significantly expand the range of tractable targets for chemical biology and therapeutic intervention.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2019        PMID: 31419624     DOI: 10.1016/j.cbpa.2019.07.003

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  26 in total

Review 1.  AKAP Signaling Islands: Venues for Precision Pharmacology.

Authors:  Mitchell H Omar; John D Scott
Journal:  Trends Pharmacol Sci       Date:  2020-10-17       Impact factor: 14.819

Review 2.  Multispecific drugs herald a new era of biopharmaceutical innovation.

Authors:  Raymond J Deshaies
Journal:  Nature       Date:  2020-04-15       Impact factor: 49.962

3.  On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugs.

Authors:  Christopher Heim; Samuel Maiwald; Christian Steinebach; Matthew K Collins; Jonathan Strope; Cindy H Chau; William D Figg; Michael Gütschow; Marcus D Hartmann
Journal:  Biochem Biophys Res Commun       Date:  2020-12-10       Impact factor: 3.575

4.  A direct high-throughput protein quantification strategy facilitates discovery and characterization of a celastrol-derived BRD4 degrader.

Authors:  N Connor Payne; Semer Maksoud; Bakhos A Tannous; Ralph Mazitschek
Journal:  Cell Chem Biol       Date:  2022-05-31       Impact factor: 9.039

Review 5.  Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation.

Authors:  Camilla Ruffilli; Sascha Roth; Monica Rodrigo; Helen Boyd; Noam Zelcer; Kevin Moreau
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-05

Review 6.  Built to last: lysosome remodeling and repair in health and disease.

Authors:  Roberto Zoncu; Rushika M Perera
Journal:  Trends Cell Biol       Date:  2022-02-02       Impact factor: 21.167

7.  Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation.

Authors:  Lu Lv; Peihao Chen; Longzhi Cao; Yamei Li; Zhi Zeng; Yue Cui; Qingcui Wu; Jiaojiao Li; Jian-Hua Wang; Meng-Qiu Dong; Xiangbing Qi; Ting Han
Journal:  Elife       Date:  2020-08-17       Impact factor: 8.140

8.  A System for the Evolution of Protein-Protein Interaction Inducers.

Authors:  Jeffrey A Dewey; Saara-Anne Azizi; Vivian Lu; Bryan C Dickinson
Journal:  ACS Synth Biol       Date:  2021-07-28       Impact factor: 5.249

Review 9.  Improved methods for targeting epigenetic reader domains of acetylated and methylated lysine.

Authors:  Isabelle A Engelberg; Caroline A Foley; Lindsey I James; Stephen V Frye
Journal:  Curr Opin Chem Biol       Date:  2021-04-11       Impact factor: 8.972

10.  An Exploration of Chemical Properties Required for Cooperative Stabilization of the 14-3-3 Interaction with NF-κB-Utilizing a Reversible Covalent Tethering Approach.

Authors:  Madita Wolter; Dario Valenti; Peter J Cossar; Stanimira Hristeva; Laura M Levy; Thorsten Genski; Torsten Hoffmann; Luc Brunsveld; Dimitrios Tzalis; Christian Ottmann
Journal:  J Med Chem       Date:  2021-06-02       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.